Optimizing utilization of sacubitril/valsartan for treatment of heart failure could improve provider performance in the Bundled Payments for Care Improvement initiative and the Medicare Shared Savings Program.
Cheryl Abbas, PharmD
Advertisement
Articles by Cheryl Abbas, PharmD
Advertisement
Latest Updated Articles
Sacubitril/Valsartan in Medicare Alternative Payment ModelsPublished: March 14th 2023 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
Promises and Pitfalls of AI in Health Care
2
Texas Sues J&J, Kenvue for Alleged Deception in Acetaminophen Marketing
3
SCRI’s Vivek Subbiah, MD, Highlights Trials on Tumor-Agnostic Cancer Therapies During ESMO
4
With New OUD Diagnoses on the Rise, More Comprehensive Screenings Needed
5
